ClinicalTrials.Veeva

Menu

Early Administration of Bifidobacterium to Very Low Birth Weight Infants

T

Tokyo Women's Medical University

Status

Completed

Conditions

Preterm Infants

Treatments

Dietary Supplement: Administration of Bifidobacterium bifidum

Study type

Interventional

Funder types

Other

Identifiers

NCT01330095
1016
UMIN000005245 (Other Identifier)

Details and patient eligibility

About

To evaluate the effects of early administration of probiotics on acceleration of enteral feeding, and on growth of very low birth weight infants, newborn infants with birth weight less than 1500g are administered Bifidobacterium bifidum twice a day.

Enrollment

36 patients

Sex

All

Ages

Under 7 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Very low birth weight infant

Exclusion criteria

  • Presence of major congenital malformations

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

36 participants in 2 patient groups

Eearly administration
Active Comparator group
Description:
Administration of Bifidobacterium within 48h after birth
Treatment:
Dietary Supplement: Administration of Bifidobacterium bifidum
Late administration
Active Comparator group
Description:
Administration of Bifidobacterium more than 48h after birth
Treatment:
Dietary Supplement: Administration of Bifidobacterium bifidum

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems